Molecular pathology lab.
±³¼ö

½Å¿µ±â ±³¼ö´Ô ¼Ò°³

Professor

½Å¿µ±â
Young Kee Shin,
M.D., Ph.D.
Á÷À§ ±³¼ö
Àü°ø º´¸®ÇÐ
Tel +82-2-880-9126
Fax +82-2-883-9126
E-mail ykeeshin@snu.ac.kr
ÁÖ¼Ò ¼­¿ï´ëÇб³ ¾ÇÇдëÇÐ 21µ¿ 220È£
Website http://molpath.snu.ac.kr
Orchid No. 0000-0003-0896-718X

Education

³âµµ Çб³ ÇÐÀ§
2000³â Seoul Nat’l Univ. Ph.D.
1998³â Seoul Nat’l Univ. M.S.
1996³â Seoul Nat’l Univ. M.D.

Work Experiences

³â µµ ±Ù¹«±â°ü¸í
2019 - present SNU, Dean of Dept. of Molecular Medicine Biopharmaceutical Sciences
2014 - present SNU, Professor , College of Pharmacy
2008 - 2014 SNU, Associate Professor, College of Pharmacy
2004 - 2008 SNU, Assistant Professor, College of Pharmacy
2001 - 2004 Seoul Nat’l Univ. Post-Doc fellow

Entrepreneurial Experience

³â µµ ±â °ü
2011 Gencurix co-founder
2007 ABION founder

Selected Important publication (Recent 3 years)

³â µµ Á¦ ¸ñ
2023 Nam JH, Kim MS, Song YJ, Kim CH, Kim WS, Yu CH, Joe HE, Hur GH, Seo MR, Kim Y, Park KE, Choi JY, Chung SJ, Shin YK.,  Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans. Arch Toxicol.  2023 Mar;97(3):697-710. doi: 10.1007/s00204-022-03438-4. Epub 2023 Jan 12.PMID: 36633609
2021 Lee CG, Kim T, Hong S, Chu J, Kang JE, Park HG, Choi JY, Song K, Rha SY, Lee S, Choi JS, Kim SM, Jeong HM, Shin YK., Antibody-based targeting of interferon-beta-1a mutein in HER2-positive cancer enhances antitumor effects through immune responses and direct cell killing. Front Pharmacol.  2021 Jan 8;11:608774. doi: 10.3389/fphar.2020.608774. eCollection 2020.